Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 69901 - 69925 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	CELSR2	1952	downregulated	Silicon Dioxide analog results in decreased expression of CELSR2 mRNA	1p13.3	A24195
Silicon dioxide	Approved	CEMIP	57214	upregulated	Silicon Dioxide analog results in increased expression of CEMIP mRNA	15q25.1	A24195
Silicon dioxide	Approved	CENPF	1063	downregulated	Silicon Dioxide analog results in decreased expression of CENPF mRNA	1q41	A24195
Silicon dioxide	Approved	CENPS	378708	downregulated	Silicon Dioxide results in decreased expression of CENPS mRNA	1p36.22	A24196
Silicon dioxide	Approved	CENPT	80152	downregulated	Silicon Dioxide analog results in decreased expression of CENPT mRNA	16q22.1	A24195
Silicon dioxide	Approved	CENPV	201161	upregulated	Silicon Dioxide analog results in increased expression of CENPV mRNA	17p11.2	A24195
Silicon dioxide	Approved	CEP44	80817	downregulated	Silicon Dioxide analog results in decreased expression of CEP44 mRNA	4q34.1	A24195
Silicon dioxide	Approved	CEP57	9702	downregulated	Silicon Dioxide results in decreased expression of CEP57 mRNA	11q21	A24196
Silicon dioxide	Approved	CEP68	23177	downregulated	Silicon Dioxide results in decreased expression of CEP68 mRNA	2p14	A24196
Silicon dioxide	Approved	CERS4	79603	downregulated	Silicon Dioxide analog results in decreased expression of CERS4 mRNA	19p13.2	A24195
Silicon dioxide	Approved	CERS6	253782	downregulated	Silicon Dioxide results in decreased expression of CERS6 mRNA	2q24.3	A24196
Silicon dioxide	Approved	CETN4P	729338	upregulated	Silicon Dioxide analog results in increased expression of CETN4P mRNA	4q27	A24195
Silicon dioxide	Approved	CFAP157	286207	downregulated	Silicon Dioxide analog results in decreased expression of CFAP157 mRNA	9q34.11	A24195
Silicon dioxide	Approved	CFAP47	286464	downregulated	Silicon Dioxide analog results in decreased expression of CFAP47 mRNA	Xp21.1	A24195
Silicon dioxide	Approved	CFAP74	85452	downregulated	Silicon Dioxide analog results in decreased expression of CFAP74 mRNA	1p36.33	A24195
Silicon dioxide	Approved	CFB	629	downregulated	Silicon Dioxide analog results in decreased expression of CFB mRNA	6p21.33	A24195
Silicon dioxide	Approved	CFB	629	upregulated	Silicon Dioxide results in increased expression of CFB mRNA	6p21.33	A24196
Silicon dioxide	Approved	CFD	1675	downregulated	Silicon Dioxide analog results in decreased expression of CFD mRNA	19p13.3	A24195
Silicon dioxide	Approved	CFH	3075	downregulated	Silicon Dioxide analog results in decreased expression of CFH mRNA	1q31.3	A24195
Silicon dioxide	Approved	CFHR3	10878	downregulated	Silicon Dioxide analog results in decreased expression of CFHR3 mRNA	1q31.3	A24195
Silicon dioxide	Approved	CFHR4	10877	downregulated	Silicon Dioxide analog results in decreased expression of CFHR4 mRNA	1q31.3	A24195
Silicon dioxide	Approved	CFI	3426	downregulated	Silicon Dioxide analog results in decreased expression of CFI mRNA	4q25	A24195
Silicon dioxide	Approved	CFTR	1080	downregulated	Silicon Dioxide analog results in decreased expression of CFTR mRNA	7q31.2	A24195
Silicon dioxide	Approved	CGA	1081	upregulated	Silicon Dioxide analog results in increased expression of CGA mRNA	6q14.3	A24194
Silicon dioxide	Approved	CGNL1	84952	downregulated	Silicon Dioxide analog results in decreased expression of CGNL1 mRNA	15q21.3	A24195

Displaying entries 69901 - 69925 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability